Answers are grounded in this paper and cite their sources.
This small single-arm trial using RMST analyses was able to detect the efficacy of AMP transplantation for advanced heart failure (compared with a registry-based control group), with better survival until 3.5 years. This approach may be useful for efficacy analyses in regenerative medicine, where traditional clinical trials are difficult.
No takes yet. Share an insight, caveat, or question.
Miyagawa et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: